Embed this press release by copying the code below:
NASDAQ: ZYNE Long Term Shareholder Notice: Investigation over Possible Wrongdoing at Zynerba Pharmaceuticals, Inc.
NASDAQ: ZYNE Long Term Shareholder Notice: Investigation over Possible Wrongdoing at Zynerba Pharmaceuticals, Inc.